TreeWAS – Variant ID: rs62212235

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44.3 Skin of other and unspecified parts of face	1.000	0.000	0.000
L57.0 Actinic keratosis	1.000	0.000	0.000
C44 Other malignant neoplasms of skin	1.000	0.000	0.000
C43 Malignant melanoma of skin	1.000	0.000	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	1.000	0.000	0.000
C44.6 Skin of upper limb, including shoulder	1.000	0.000	0.000
C43.5 Malignant melanoma of trunk	1.000	0.000	0.000
C44.4 Skin of scalp and neck	1.000	0.000	0.000
C44.5 Skin of trunk	1.000	0.000	0.000
Z85.8 Personal history of malignant neoplasms of other organs and systems	1.000	0.000	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	1.000	0.000	0.000
C44.1 Skin of eyelid, including canthus	1.000	0.000	0.000
Chapter II Neoplasms	0.999	0.001	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.999	0.001	0.000
L90 Atrophic disorders of skin	0.997	0.003	0.000
L90.5 Scar conditions and fibrosis of skin	0.997	0.003	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.997	0.003	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.995	0.005	0.000
L81 Other disorders of pigmentation	0.994	0.006	0.000
L85 Other epidermal thickening	0.993	0.007	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.993	0.007	0.000
C64-C68 Malignant neoplasms of urinary tract	0.990	0.010	0.000
L81.4 Other melanin hyperpigmentation	0.989	0.011	0.000
D00-D09 In situ neoplasms	0.988	0.012	0.000
C50-C50 Malignant neoplasm of breast	0.980	0.020	0.000
D03 Melanoma in situ	0.978	0.022	0.000
C44.2 Skin of ear and external auricular canal	0.978	0.022	0.000
C50 Malignant neoplasm of breast	0.966	0.034	0.000
C67 Malignant neoplasm of bladder	0.965	0.035	0.000
L85.9 Epidermal thickening, unspecified	0.964	0.036	0.000
C43.4 Malignant melanoma of scalp and neck	0.957	0.043	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.952	0.048	0.000
D03.5 Melanoma in situ of trunk	0.946	0.054	0.000
L85.8 Other specified epidermal thickening	0.944	0.056	0.000
C44.0 Skin of lip	0.925	0.075	0.000
C44.7 Skin of lower limb, including hip	0.924	0.076	0.000
C71 Malignant neoplasm of brain	0.917	0.083	0.000
C50.3 Lower-inner quadrant of breast	0.908	0.092	0.000
N40 Hyperplasia of prostate	0.898	0.102	0.000
C65 Malignant neoplasm of renal pelvis	0.871	0.129	0.000
L81.8 Other specified disorders of pigmentation	0.871	0.129	0.000
C66 Malignant neoplasm of ureter	0.867	0.133	0.000
C50.8 Overlapping lesion of breast	0.860	0.140	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.855	0.145	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.853	0.147	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.849	0.151	0.000
C50.2 Upper-inner quadrant of breast	0.849	0.151	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.849	0.151	0.000
C71.0 Cerebrum, except lobes and ventricles	0.842	0.158	0.000
C71.9 Brain, unspecified	0.833	0.167	0.000
C43.9 Malignant melanoma of skin, unspecified	0.832	0.168	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.823	0.177	0.000
C67.8 Overlapping lesion of bladder	0.819	0.181	0.000
C50.4 Upper-outer quadrant of breast	0.814	0.186	0.000
C67.9 Bladder, unspecified	0.808	0.192	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.806	0.194	0.000
L94 Other localised connective tissue disorders	0.797	0.203	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.790	0.210	0.000
C67.6 Ureteric orifice	0.788	0.212	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.786	0.214	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.782	0.218	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.781	0.219	0.000
L81.2 Freckles	0.774	0.226	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.771	0.229	0.000
D07.5 Prostate	0.768	0.232	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.768	0.232	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.767	0.232	0.000
C50.5 Lower-outer quadrant of breast	0.768	0.232	0.000
L10-L14 Bullous disorders	0.764	0.236	0.000
D04 Carcinoma in situ of skin	0.763	0.237	0.000
C67.5 Bladder neck	0.761	0.239	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.760	0.240	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.758	0.242	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.757	0.243	0.000
C67.2 Lateral wall of bladder	0.757	0.243	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.757	0.243	0.000
D03.4 Melanoma in situ of scalp and neck	0.749	0.251	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.746	0.253	0.000
L83 Acanthosis nigricans	0.745	0.254	0.000
C67.0 Trigone of bladder	0.743	0.257	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.741	0.259	0.000
D05 Carcinoma in situ of breast	0.734	0.266	0.000
C50.0 Nipple and areola	0.732	0.268	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.731	0.269	0.000
D09 Carcinoma in situ of other and unspecified sites	0.729	0.271	0.000
C67.4 Posterior wall of bladder	0.729	0.271	0.000
C67.1 Dome of bladder	0.724	0.276	0.000
D46 Myelodysplastic syndromes	0.720	0.280	0.000
C43.8 Overlapping malignant melanoma of skin	0.717	0.283	0.000
C43.0 Malignant melanoma of lip	0.717	0.283	0.000
C44.8 Overlapping lesion of skin	0.717	0.283	0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.716	0.284	0.000
L87 Transepidermal elimination disorders	0.716	0.284	0.000
L88 Pyoderma gangrenosum	0.716	0.284	0.000
L86 Keratoderma in diseases classified elsewhere	0.716	0.284	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.715	0.285	0.000
L90.9 Atrophic disorder of skin, unspecified	0.715	0.285	0.000
L90.8 Other atrophic disorders of skin	0.715	0.285	0.000
L90.6 Striae atrophicae	0.715	0.285	0.000
L90.4 Acrodermatitis chronica atrophicans	0.715	0.285	0.000
L90.3 Atrophoderma of Pasini and Pierini	0.715	0.285	0.000
L90.2 Anetoderma of Jadassohn-Pellizzari	0.715	0.285	0.000
L90.1 Anetoderma of Schweninger-Buzzi	0.715	0.285	0.000
L57.5 Actinic granuloma	0.715	0.285	0.000
L57.3 Poikiloderma of Civatte	0.715	0.285	0.000
L57.2 Cutis rhomboidalis nuchae	0.715	0.285	0.000
L57.1 Actinic reticuloid	0.715	0.285	0.000
C67.3 Anterior wall of bladder	0.715	0.285	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.713	0.287	0.000
L58 Radiodermatitis	0.713	0.287	0.000
L55 Sunburn	0.713	0.287	0.000
L81.7 Pigmented purpuric dermatosis	0.713	0.287	0.000
L81.6 Other disorders of diminished melanin formation	0.713	0.287	0.000
L81.5 Leukoderma, not elsewhere classified	0.713	0.287	0.000
L81.3 Cafe au lait spots	0.713	0.287	0.000
L81.1 Chloasma	0.713	0.287	0.000
L81.0 Postinflammatory hyperpigmentation	0.713	0.287	0.000
L85.3 Xerosis cutis	0.712	0.288	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.712	0.288	0.000
L85.0 Acquired ichthyosis	0.712	0.288	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.710	0.290	0.000
C50.6 Axillary tail of breast	0.706	0.294	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.702	0.298	0.000
D03.9 Melanoma in situ, unspecified	0.701	0.299	0.000
D03.8 Melanoma in situ of other sites	0.701	0.299	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.701	0.299	0.000
D03.0 Melanoma in situ of lip	0.701	0.299	0.000
L93 Lupus erythematosus	0.700	0.300	0.000
C71.3 Parietal lobe	0.698	0.302	0.000
C69 Malignant neoplasm of eye and adnexa	0.696	0.304	0.000
L60-L75 Disorders of skin appendages	0.693	0.307	0.000
C04 Malignant neoplasm of floor of mouth	0.693	0.307	0.000
C67.7 Urachus	0.692	0.308	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.687	0.313	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.685	0.315	0.000
C13 Malignant neoplasm of hypopharynx	0.685	0.315	0.000
C90.0 Multiple myeloma	0.683	0.317	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.683	0.317	0.000
C70 Malignant neoplasm of meninges	0.683	0.317	0.000
L94.2 Calcinosis cutis	0.682	0.317	0.000
L91 Hypertrophic disorders of skin	0.681	0.319	0.000
C71.4 Occipital lobe	0.674	0.326	0.000
L89 Decubitus ulcer	0.672	0.328	0.000
L50-L54 Urticaria and erythema	0.671	0.329	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.671	0.329	0.000
L95 Vasculitis limited to skin, not elsewhere classified	0.668	0.332	0.000
C50.1 Central portion of breast	0.667	0.333	0.000
L57.4 Cutis laxa senilis	0.666	0.333	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.665	0.335	0.000
C71.2 Temporal lobe	0.661	0.339	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.660	0.340	0.000
C71.8 Overlapping lesion of brain	0.657	0.342	0.000
C71.7 Brain stem	0.657	0.342	0.000
C71.6 Cerebellum	0.657	0.342	0.000
C71.5 Cerebral ventricle	0.657	0.342	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.657	0.343	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.653	0.347	0.000
C10 Malignant neoplasm of oropharynx	0.651	0.349	0.000
D05.0 Lobular carcinoma in situ	0.637	0.363	0.000
D07.4 Penis	0.635	0.365	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.633	0.367	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.633	0.367	0.000
C01 Malignant neoplasm of base of tongue	0.633	0.367	0.000
D04.2 Skin of ear and external auricular canal	0.627	0.373	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.625	0.375	0.000
L72 Follicular cysts of skin and subcutaneous tissue	0.619	0.381	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.617	0.383	0.000
L98.1 Factitial dermatitis	0.614	0.386	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.612	0.388	0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.612	0.388	0.000
C11 Malignant neoplasm of nasopharynx	0.609	0.391	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.609	0.391	0.000
C05 Malignant neoplasm of palate	0.609	0.391	0.000
C03 Malignant neoplasm of gum	0.609	0.391	0.000
C00 Malignant neoplasm of lip	0.609	0.391	0.000
D07.6 Other and unspecified male genital organs	0.608	0.392	0.000
D07.3 Other and unspecified female genital organs	0.608	0.392	0.000
D07.2 Vagina	0.608	0.392	0.000
D07.0 Endometrium	0.608	0.392	0.000
M20.4 Other hammer toe(s) (acquired)	0.607	0.393	0.000
M20 Acquired deformities of fingers and toes	0.607	0.393	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.606	0.394	0.000
C90.2 Plasmacytoma, extramedullary	0.605	0.395	0.000
C12 Malignant neoplasm of pyriform sinus	0.601	0.399	0.000
M20.1 Hallux valgus (acquired)	0.601	0.399	0.000
L12 Pemphigoid	0.600	0.400	0.000
L72.1 Trichilemmal cyst	0.597	0.403	0.000
D09.1 Other and unspecified urinary organs	0.596	0.404	0.000
C09 Malignant neoplasm of tonsil	0.593	0.407	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.590	0.410	0.000
D46.4 Refractory anaemia, unspecified	0.584	0.416	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.584	0.416	0.000
D05.7 Other carcinoma in situ of breast	0.584	0.416	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.583	0.417	0.000
C04.9 Floor of mouth, unspecified	0.581	0.419	0.000
L91.0 Keloid scar	0.578	0.422	0.000
L80 Vitiligo	0.575	0.425	0.000
D04.7 Skin of lower limb, including hip	0.574	0.426	0.000
L94.9 Localised connective tissue disorder, unspecified	0.572	0.428	0.000
L94.8 Other specified localised connective tissue disorders	0.572	0.428	0.000
L94.6 Ainhum	0.572	0.428	0.000
L94.5 Poikiloderma vasculare atrophicans	0.572	0.428	0.000
L94.4 Gottron's papules	0.572	0.428	0.000
L94.3 Sclerodactyly	0.572	0.428	0.000
L94.1 Linear scleroderma	0.572	0.428	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.571	0.429	0.000
C71.1 Frontal lobe	0.569	0.431	0.000
C13.9 Hypopharynx, unspecified	0.567	0.433	0.000
D04.5 Skin of trunk	0.566	0.434	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.564	0.436	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.564	0.436	0.000
L56.4 Polymorphous light eruption	0.561	0.439	0.000
L56.3 Solar urticaria	0.561	0.439	0.000
L56.2 Photocontact dermatitis [berloque dermatitis]	0.561	0.439	0.000
L56.1 Drug photoallergic response	0.561	0.439	0.000
L56.0 Drug phototoxic response	0.561	0.439	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.560	0.440	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.560	0.440	0.000
M20-M25 Other joint disorders	0.559	0.441	0.000
L50 Urticaria	0.557	0.443	0.000
C73 Malignant neoplasm of thyroid gland	0.556	0.444	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.555	0.445	0.000
C81 Hodgkin's disease	0.550	0.450	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.548	0.452	0.000
D04.6 Skin of upper limb, including shoulder	0.548	0.452	0.000
L13 Other bullous disorders	0.548	0.452	0.000
L11 Other acantholytic disorders	0.548	0.452	0.000
L10 Pemphigus	0.548	0.452	0.000
L14 Bullous disorders in diseases classified elsewhere	0.548	0.452	0.000
D04.9 Skin, unspecified	0.547	0.453	0.000
D04.8 Skin of other sites	0.547	0.453	0.000
D04.1 Skin of eyelid, including canthus	0.547	0.453	0.000
D04.0 Skin of lip	0.547	0.453	0.000
D01.3 Anus and anal canal	0.547	0.453	0.000
D04.4 Skin of scalp and neck	0.546	0.454	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.546	0.454	0.000
D45 Polycythaemia vera	0.543	0.457	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.543	0.457	0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.543	0.457	0.000
L98.5 Mucinosis of skin	0.543	0.457	0.000
L98.3 Eosinophilic cellulitis [Wells]	0.543	0.457	0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.543	0.457	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.543	0.457	0.000
C46 Kaposi's sarcoma	0.543	0.457	0.000
D46.2 Refractory anaemia with excess of blasts	0.541	0.459	0.000
M24 Other specific joint derangements	0.538	0.462	0.000
C07 Malignant neoplasm of parotid gland	0.538	0.462	0.000
M20.0 Deformity of finger(s)	0.536	0.464	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.535	0.465	0.000
L81.9 Disorder of pigmentation, unspecified	0.533	0.467	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.531	0.469	0.000
C74 Malignant neoplasm of adrenal gland	0.531	0.469	0.000
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.525	0.475	0.000
D01.9 Digestive organ, unspecified	0.524	0.476	0.000
D01.7 Other specified digestive organs	0.524	0.476	0.000
D01.5 Liver, gallbladder and bile ducts	0.524	0.476	0.000
D01.4 Other and unspecified parts of intestine	0.524	0.476	0.000
D01.2 Rectum	0.524	0.476	0.000
D01.1 Rectosigmoid junction	0.524	0.476	0.000
D01.0 Colon	0.524	0.476	0.000
D09.9 Carcinoma in situ, unspecified	0.523	0.477	0.000
D09.7 Carcinoma in situ of other specified sites	0.523	0.477	0.000
D09.3 Thyroid and other endocrine glands	0.523	0.477	0.000
D09.2 Eye	0.523	0.477	0.000
C14.0 Pharynx, unspecified	0.520	0.480	0.000
D46.7 Other myelodysplastic syndromes	0.516	0.484	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.516	0.484	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.516	0.484	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.516	0.484	0.000
D46.1 Refractory anaemia with sideroblasts	0.516	0.484	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.516	0.484	0.000
M21 Other acquired deformities of limbs	0.516	0.484	0.000
L94.0 Localised scleroderma [morphea]	0.514	0.486	0.000
L87.9 Transepidermal elimination disorder, unspecified	0.513	0.486	0.000
L87.8 Other transepidermal elimination disorders	0.513	0.486	0.000
L87.2 Elastosis perforans serpiginosa	0.513	0.486	0.000
L87.1 Reactive perforating collagenosis	0.513	0.486	0.000
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.513	0.486	0.000
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.513	0.486	0.000
L99.0 Amyloidosis of skin	0.513	0.486	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.513	0.487	0.000
C94 Other leukaemias of specified cell type	0.513	0.487	0.000
C93 Monocytic leukaemia	0.513	0.487	0.000
C86 Other specified types of T/NK-cell lymphoma	0.513	0.487	0.000
C06.2 Retromolar area	0.512	0.488	0.000
D07.1 Vulva	0.512	0.488	0.000
L55.9 Sunburn, unspecified	0.511	0.489	0.000
L55.8 Other sunburn	0.511	0.489	0.000
L55.2 Sunburn of third degree	0.511	0.489	0.000
L55.1 Sunburn of second degree	0.511	0.489	0.000
L55.0 Sunburn of first degree	0.511	0.489	0.000
L58.9 Radiodermatitis, unspecified	0.511	0.489	0.000
L58.1 Chronic radiodermatitis	0.511	0.489	0.000
L58.0 Acute radiodermatitis	0.511	0.489	0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.511	0.489	0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.511	0.489	0.000
L59.0 Erythema ab igne [dermatitis ab igne]	0.511	0.489	0.000
C69.9 Eye, unspecified	0.511	0.489	0.000
C10.9 Oropharynx, unspecified	0.509	0.490	0.000
C68.9 Urinary organ, unspecified	0.509	0.491	0.000
C68.8 Overlapping lesion of urinary organs	0.509	0.491	0.000
C68.1 Paraurethral glands	0.509	0.491	0.000
C68.0 Urethra	0.509	0.491	0.000
D43.2 Brain, unspecified	0.508	0.492	0.000
L70 Acne	0.508	0.492	0.000
C92 Myeloid leukaemia	0.508	0.492	0.000
D06 Carcinoma in situ of cervix uteri	0.507	0.493	0.000
C90.3 Solitary plasmacytoma	0.504	0.496	0.000
C90.1 Plasma cell leukaemia	0.504	0.496	0.000
L93.2 Other local lupus erythematosus	0.502	0.498	0.000
L93.1 Subacute cutaneous lupus erythematosus	0.502	0.498	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.501	0.499	0.000
C69.3 Choroid	0.500	0.500	0.000
C69.8 Overlapping lesion of eye and adnexa	0.499	0.501	0.000
C69.6 Orbit	0.499	0.501	0.000
C69.5 Lachrymal gland and duct	0.499	0.501	0.000
C69.4 Ciliary body	0.499	0.501	0.000
C69.2 Retina	0.499	0.501	0.000
C69.1 Cornea	0.499	0.501	0.000
C69.0 Conjunctiva	0.499	0.501	0.000
C95 Leukaemia of unspecified cell type	0.498	0.502	0.000
D41.0 Kidney	0.498	0.502	0.000
M24.2 Disorder of ligament	0.497	0.503	0.000
L75 Apocrine sweat disorders	0.497	0.503	0.000
L74 Eccrine sweat disorders	0.497	0.503	0.000
L68 Hypertrichosis	0.497	0.503	0.000
L67 Hair colour and hair shaft abnormalities	0.497	0.503	0.000
L66 Cicatricial alopecia [scarring hair loss]	0.497	0.503	0.000
L64 Androgenic alopecia	0.497	0.503	0.000
L63 Alopecia areata	0.497	0.503	0.000
L62 Nail disorders in diseases classified elsewhere	0.497	0.503	0.000
C04.8 Overlapping lesion of floor of mouth	0.497	0.503	0.000
C04.1 Lateral floor of mouth	0.497	0.503	0.000
C04.0 Anterior floor of mouth	0.497	0.503	0.000
L89.1 Stage II decubitus ulcer	0.497	0.503	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.495	0.505	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.492	0.508	0.000
C13.8 Overlapping lesion of hypopharynx	0.491	0.509	0.000
C13.2 Posterior wall of hypopharynx	0.491	0.509	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.491	0.509	0.000
C13.0 Postcricoid region	0.491	0.509	0.000
C70.9 Meninges, unspecified	0.489	0.510	0.000
C70.1 Spinal meninges	0.489	0.510	0.000
C70.0 Cerebral meninges	0.489	0.510	0.000
C72.9 Central nervous system, unspecified	0.489	0.510	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.489	0.510	0.000
C72.5 Other and unspecified cranial nerves	0.489	0.510	0.000
C72.4 Acoustic nerve	0.489	0.510	0.000
C72.3 Optic nerve	0.489	0.510	0.000
C72.2 Olfactory nerve	0.489	0.510	0.000
C72.1 Cauda equina	0.489	0.510	0.000
C72.0 Spinal cord	0.489	0.510	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.488	0.512	0.000
L60 Nail disorders	0.486	0.514	0.000
C41.1 Mandible	0.486	0.514	0.000
C49.5 Connective and soft tissue of pelvis	0.486	0.514	0.000
L93.0 Discoid lupus erythematosus	0.486	0.514	0.000
L12.0 Bullous pemphigoid	0.483	0.517	0.000
C41.0 Bones of skull and face	0.481	0.518	0.000
L54 Erythema in diseases classified elsewhere	0.481	0.518	0.000
L51 Erythema multiforme	0.481	0.518	0.000
L95.8 Other vasculitis limited to skin	0.479	0.521	0.000
L95.1 Erythema elevatum diutinum	0.479	0.521	0.000
L95.0 Livedoid vasculitis	0.479	0.521	0.000
L89.2 Stage III decubitus ulcer	0.477	0.523	0.000
C49.0 Connective and soft tissue of head, face and neck	0.476	0.524	0.000
L71 Rosacea	0.475	0.525	0.000
D00.2 Stomach	0.473	0.526	0.000
D00.1 Oesophagus	0.473	0.526	0.000
C48.0 Retroperitoneum	0.472	0.528	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.471	0.529	0.000
C14.2 Waldeyer's ring	0.471	0.529	0.000
D43.0 Brain, supratentorial	0.469	0.531	0.000
C06.9 Mouth, unspecified	0.468	0.532	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.468	0.532	0.000
C06.1 Vestibule of mouth	0.468	0.532	0.000
C06.0 Cheek mucosa	0.468	0.532	0.000
C10.8 Overlapping lesion of oropharynx	0.467	0.533	0.000
C10.4 Branchial cleft	0.467	0.533	0.000
C10.3 Posterior wall of oropharynx	0.467	0.533	0.000
C10.2 Lateral wall of oropharynx	0.467	0.533	0.000
C10.1 Anterior surface of epiglottis	0.467	0.533	0.000
C10.0 Vallecula	0.467	0.533	0.000
D41.4 Bladder	0.466	0.534	0.000
M20.5 Other deformities of toe(s) (acquired)	0.464	0.536	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.463	0.537	0.000
C81.1 Nodular sclerosis	0.463	0.537	0.000
C32 Malignant neoplasm of larynx	0.462	0.538	0.000
L89.3 Stage IV decubitus ulcer	0.461	0.539	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.458	0.541	0.000
M32 Systemic lupus erythematosus	0.458	0.542	0.000
M20.6 Acquired deformity of toe(s), unspecified	0.458	0.542	0.000
M30 Polyarteritis nodosa and related conditions	0.457	0.543	0.000
D02.4 Respiratory system, unspecified	0.454	0.546	0.000
D02.3 Other parts of respiratory system	0.454	0.546	0.000
D02.2 Bronchus and lung	0.454	0.546	0.000
D02.1 Trachea	0.454	0.546	0.000
L40-L45 Papulosquamous disorders	0.453	0.546	0.000
M24.26 Disorder of ligament (Lower leg)	0.453	0.547	0.000
L50.0 Allergic urticaria	0.451	0.549	0.000
C60-C63 Malignant neoplasms of male genital organs	0.451	0.549	0.000
C41.9 Bone and articular cartilage, unspecified	0.448	0.552	0.000
C41.8 Overlapping lesion of bone and articular cartilage	0.448	0.552	0.000
C41.4 Pelvic bones, sacrum and coccyx	0.448	0.552	0.000
C41.3 Ribs, sternum and clavicle	0.448	0.552	0.000
C41.2 Vertebral column	0.448	0.552	0.000
L52 Erythema nodosum	0.445	0.555	0.000
L98.0 Pyogenic granuloma	0.445	0.555	0.000
C48.1 Specified parts of peritoneum	0.445	0.555	0.000
D04.3 Skin of other and unspecified parts of face	0.444	0.555	0.000
L72.2 Steatocystoma multiplex	0.444	0.556	0.000
D44.8 Pluriglandular involvement	0.444	0.556	0.000
D43.9 Central nervous system, unspecified	0.443	0.557	0.000
D43.7 Other parts of central nervous system	0.443	0.557	0.000
D43.4 Spinal cord	0.443	0.557	0.000
D43.3 Cranial nerves	0.443	0.557	0.000
D43.1 Brain, infratentorial	0.443	0.557	0.000
C45 Mesothelioma	0.442	0.558	0.000
D09.0 Bladder	0.441	0.558	0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.441	0.559	0.000
D41.9 Urinary organ, unspecified	0.439	0.561	0.000
D41.7 Other urinary organs	0.439	0.561	0.000
D41.3 Urethra	0.439	0.561	0.000
D41.2 Ureter	0.439	0.561	0.000
D41.1 Renal pelvis	0.439	0.561	0.000
L50.9 Urticaria, unspecified	0.437	0.563	0.000
C00.9 Lip, unspecified	0.436	0.563	0.000
C00.8 Overlapping lesion of lip	0.436	0.563	0.000
C00.6 Commissure of lip	0.436	0.563	0.000
C00.5 Lip, unspecified, inner aspect	0.436	0.563	0.000
C00.4 Lower lip, inner aspect	0.436	0.563	0.000
C00.3 Upper lip, inner aspect	0.436	0.563	0.000
C00.2 External lip, unspecified	0.436	0.563	0.000
C00.1 External lower lip	0.436	0.563	0.000
C00.0 External upper lip	0.436	0.563	0.000
C03.9 Gum, unspecified	0.436	0.563	0.000
C03.1 Lower gum	0.436	0.563	0.000
C03.0 Upper gum	0.436	0.563	0.000
C05.9 Palate, unspecified	0.436	0.563	0.000
C05.8 Overlapping lesion of palate	0.436	0.563	0.000
C05.2 Uvula	0.436	0.563	0.000
C05.1 Soft palate	0.436	0.563	0.000
C05.0 Hard palate	0.436	0.563	0.000
C08.9 Major salivary gland, unspecified	0.436	0.563	0.000
C08.8 Overlapping lesion of major salivary glands	0.436	0.563	0.000
C08.1 Sublingual gland	0.436	0.563	0.000
C08.0 Submandibular gland	0.436	0.563	0.000
C11.9 Nasopharynx, unspecified	0.436	0.563	0.000
C11.8 Overlapping lesion of nasopharynx	0.436	0.563	0.000
C11.3 Anterior wall of nasopharynx	0.436	0.563	0.000
C11.2 Lateral wall of nasopharynx	0.436	0.563	0.000
C11.1 Posterior wall of nasopharynx	0.436	0.563	0.000
C11.0 Superior wall of nasopharynx	0.436	0.563	0.000
C88 Malignant immunoproliferative diseases	0.436	0.564	0.000
M24.1 Other articular cartilage disorders	0.435	0.565	0.000
C49.9 Connective and soft tissue, unspecified	0.434	0.565	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.434	0.565	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.434	0.565	0.000
C49.4 Connective and soft tissue of abdomen	0.434	0.565	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.434	0.565	0.000
M24.4 Recurrent dislocation and subluxation of joint	0.434	0.566	0.000
M25 Other joint disorders, not elsewhere classified	0.434	0.566	0.000
M21.6 Other acquired deformities of ankle and foot	0.433	0.567	0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.432	0.568	0.000
L95.9 Vasculitis limited to skin, unspecified	0.431	0.568	0.000
L82 Seborrhoeic keratosis	0.431	0.569	0.000
L12.9 Pemphigoid, unspecified	0.430	0.569	0.000
L12.8 Other pemphigoid	0.430	0.569	0.000
L12.3 Acquired epidermolysis bullosa	0.430	0.569	0.000
L12.2 Chronic bullous disease of childhood	0.430	0.569	0.000
L12.1 Cicatricial pemphigoid	0.430	0.569	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.430	0.570	0.000
M24.6 Ankylosis of joint	0.427	0.573	0.000
C84.4 Peripheral T-cell lymphoma	0.426	0.574	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.426	0.574	0.001
C09.8 Overlapping lesion of tonsil	0.425	0.574	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.425	0.574	0.000
C09.0 Tonsillar fossa	0.425	0.574	0.000
D00.0 Lip, oral cavity and pharynx	0.425	0.575	0.000
M80-M85 Disorders of bone density and structure	0.424	0.576	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.423	0.577	0.000
M21.4 Flat foot [pes planus] (acquired)	0.419	0.580	0.000
M21.3 Wrist or foot drop (acquired)	0.417	0.583	0.000
M21.7 Unequal limb length (acquired)	0.414	0.586	0.000
C84.5 Other and unspecified T-cell lymphomas	0.414	0.586	0.000
D44.3 Pituitary gland	0.410	0.589	0.000
C09.9 Tonsil, unspecified	0.410	0.590	0.000
D44.9 Endocrine gland, unspecified	0.409	0.591	0.000
D44.7 Aortic body and other paraganglia	0.409	0.591	0.000
D44.6 Carotid body	0.409	0.591	0.000
D44.5 Pineal gland	0.409	0.591	0.000
D44.4 Craniopharyngeal duct	0.409	0.591	0.000
D44.2 Parathyroid gland	0.409	0.591	0.000
D44.1 Adrenal gland	0.409	0.591	0.000
D44.0 Thyroid gland	0.409	0.591	0.000
M21.1 Varus deformity, not elsewhere classified	0.409	0.591	0.000
M22 Disorders of patella	0.406	0.594	0.000
C49.3 Connective and soft tissue of thorax	0.406	0.594	0.000
L60.2 Onychogryphosis	0.405	0.595	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.404	0.596	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations